Literature DB >> 23714811

The role of silicone granulomas in recurrent capsular contracture: a review of the literature and an approach to management.

Elisabeth H Potter1, Rod J Rohrich, Kelly M Bolden.   

Abstract

BACKGROUND: The silicone granuloma was first described in the literature in 1964. During the course of clinical practice, the plastic surgeon will encounter a silicone granuloma in a breast augmentation or reconstruction patient. This review addresses the clinical significance associated with silicone granulomas. Clinical implications and indications for intervention are discussed, and a reasonable management algorithm is proposed.
METHODS: A review of the literature relating to silicone granulomas and their clinical implications was performed.
RESULTS: Although case series have been reported, there is no consensus regarding the treatment of silicone granulomas.
CONCLUSIONS: This important clinical entity warrants investigative attention to better understand its clinical implications and prevention. An algorithm for treatment is proposed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23714811     DOI: 10.1097/PRS.0b013e31828bd642

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  3 in total

1.  Foreign Body Reaction after Implantation of a Device for Intervertebral Assisted Motion.

Authors:  Jun-Yeong Seo; Kee-Yong Ha; Young-Hoon Kim; Joo-Hyun Ahn
Journal:  J Korean Neurosurg Soc       Date:  2016-10-24

2.  Poly Implant Prothèse silicone breast implants: implant dynamics and capsular contracture.

Authors:  Y Bachour; Z C M Heinze; T S Dormaar; W G van Selms; M J P F Ritt; F B Niessen
Journal:  Eur J Plast Surg       Date:  2018-06-01

3.  The Histological Composition of Capsular Contracture Focussed on the Inner Layer of the Capsule: An Intra-Donor Baker-I Versus Baker-IV Comparison.

Authors:  E de Bakker; L J van den Broek; M J P F Ritt; S Gibbs; F B Niessen
Journal:  Aesthetic Plast Surg       Date:  2018-09-05       Impact factor: 2.326

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.